Trifluridine
Showing 1 - 25 of 87
Trifluridine/Tipiracil Plus Bevacizumab Versus
Completed
- Metastatic Colorectal Adenocarcinoma
-
Changsha, Hunan, ChinaHunan Cancer hospital
May 11, 2023
Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)
Recruiting
- Metastatic Colorectal Cancer
- Envafolimab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Sep 24, 2023
Metastatic Colorectal Cancer Trial in Berlin (Panitumumab 20 milligram/ML, Bevacizumab, Trifluridine/Tipiracil Hydrochloride)
Recruiting
- Metastatic Colorectal Cancer
- Panitumumab 20 milligram/ML
- +2 more
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Jul 20, 2022
Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)
Not yet recruiting
- Rectal Cancer
- Trifluridine/Tipiracil
- intensity-modulated radiotherapy
- (no location specified)
Jul 27, 2023
Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)
Recruiting
- Metastatic Colorectal Cancer
- Futuximab/modotuximab
- Trifluridine/Tipiracil
-
Ann Arbor, Michigan
- +10 more
Dec 2, 2022
Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)
Terminated
- Cholangiocarcinoma
- Bile Duct Cancer
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Nov 28, 2022
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,
Active, not recruiting
- Advanced Bile Duct Carcinoma
- +17 more
- Irinotecan
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 5, 2023
Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7 Trial in Scottsdale, Rochester
Active, not recruiting
- Cholangiocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Trifluridine/Tipiracil Hydrochloride Combination Agent TAS-102
-
Scottsdale, Arizona
- +1 more
Jan 4, 2023
Gastric and Gastroesophageal Junction Adenocarcinoma Trial (Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®))
Not yet recruiting
- Gastric and Gastroesophageal Junction Adenocarcinoma
- Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®)
- (no location specified)
Aug 17, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Metastatic Colorectal Cancer Trial in United States (Rivoceranib, Trifluridine/Tipiracil)
Active, not recruiting
- Metastatic Colorectal Cancer
-
Sarasota, Florida
- +3 more
May 18, 2022
Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Trifluridine/Tipiracil)
Recruiting
- Metastatic Colorectal Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 24, 2023
Metastatic Colorectal Cancer Trial (trifluridine/tipiracil + XB2001, trifluridine/tipiracil + )
Not yet recruiting
- Metastatic Colorectal Cancer
- trifluridine/tipiracil + XB2001
- trifluridine/tipiracil + placebo
- (no location specified)
Jan 15, 2022
Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)
Recruiting
- Cholangiocarcinoma
- Combination of Lonsurf® and Irinotecan
-
Düsseldorf, NRW, GermanyKlinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022
Called STAR-T to Learn More About Sequential Treatment With
Not yet recruiting
- Metastatic Colorectal Cancer (mCRC)
- Regorafenib (BAY73-4506, Stivarga®)
- +2 more
-
Whippany, New JerseyMany locations
Apr 21, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +5 more
- Trastuzumab
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 31, 2023
Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])
Completed
- Metastatic Colon Cancer
- Trifluridine Tipiracil
- Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
-
Monserrato, CA, Italy
- +7 more
Jul 21, 2022
Metastatic Colorectal Cancer Trial in France (Regorafenib then Trifluridine/Tipiracil, Trifluridine/Tipiracil then Regorafenib)
Recruiting
- Metastatic Colorectal Cancer
- Regorafenib then Trifluridine/Tipiracil
- Trifluridine/Tipiracil then Regorafenib
-
Bouge, Belgium
- +37 more
Dec 14, 2022
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece
Completed
- Metastatic Colorectal Cancer
-
Heraklion, Crete, Greece
- +7 more
Mar 4, 2022
Rectal Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IV Rectal Cancer AJCC v7 Trial in Scottsdale, Rochester (other,
Completed
- Rectal Adenocarcinoma
- +4 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +1 more
Jan 3, 2023
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Elizabeth, New Jersey
- +5 more
Oct 17, 2022